MedPath

METHOCARBAMOL

METHOCARBAMOL

Approved
Approval ID

9145aa4c-48f8-de34-e053-2995a90a6a3c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 6, 2023

Manufacturers
FDA

Direct_Rx

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

METHOCARBAMOL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61919-903
Application NumberANDA090200
Product Classification
M
Marketing Category
C73584
G
Generic Name
METHOCARBAMOL
Product Specifications
Route of AdministrationORAL
Effective DateJune 6, 2023
FDA Product Classification

INGREDIENTS (9)

STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
POVIDONE K90Inactive
Code: RDH86HJV5Z
Classification: IACT
METHOCARBAMOLActive
Quantity: 750 mg in 1 1
Code: 125OD7737X
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.